JFrog arrives at its May 8 earnings release on the back of a striking short-cover rally — the real story heading into tonight's print isn't bearish pressure, it's the dramatic retreat of it.
Short sellers have been cutting exposure at an unusual pace. Short interest has fallen 35% over the past month to 4.6% of the free float, a level that was closer to 7.4% at the start of April. That compression coincided almost exactly with the stock's 23% surge over the past week, closing at $57.02 on May 7 — up 6% on the day alone. The borrow market reflects this receding pressure: availability is very loose, with cost to borrow running at just 0.46%, and the ORTEX short score has eased to 38.3, well below its late-April reading of 42. Bears have been retreating, not loading up.
Options traders are equally relaxed into the print. The put/call ratio is running at just 0.24 — near the lower end of its 52-week range of 0.19 to 0.88, and fractionally below its 20-day average of 0.25. There is no meaningful hedging demand on display. That is an unusually bullish options posture heading into an earnings release that, one quarter ago, delivered a 10.8% single-day drop followed by a 29% five-day slide — the kind of print that typically prompts more caution.
The bull case centers on JFrog's positioning in AI-enabled software delivery and secure developer tooling, an area where demand is accelerating. Forward EPS growth ranks in the 99th percentile across the ORTEX universe — a standout metric that suggests the Street sees meaningful earnings expansion ahead, even if the stock's current P/E of 55.6x and EV/EBITDA of 45x leave little room for disappointment. Analysts have kept their Buy ratings intact across the board, though several firms — including BTIG and TD Cowen — trimmed targets in recent weeks to the $60–$70 range, pulling the consensus mean price target to $67.30, roughly 18% above the current price. The bear case focuses on US market concentration, cloud revenue volatility quarter-to-quarter, and macro exposure that could weigh on developer-seat growth. Cantor Fitzgerald held its $80 target and Overweight rating, the most optimistic voice on the Street.
One nuance worth noting is the insider picture. Multiple founders — CEO Shlomi Ben Haim, CTO Yoav Landman, and director Frederic Simon — sold a combined ~$4 million of stock in early April, when the share price was in the $42–$50 range. The stock has since rallied well past those exit levels, which adds an interesting wrinkle to the ownership narrative. JP Morgan Asset Management and Invesco both added meaningfully to their positions in Q1, while Whale Rock Capital more than doubled its stake as of December — evidence that institutional conviction has been building even as founders lightened up.
Tonight's print will test whether the fundamental delivery — particularly cloud revenue trajectory and any commentary on AI workload adoption — can substantiate the sharp re-rating the stock has already enjoyed this week.
See the live data behind this article on ORTEX.
Open FROG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
